Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > GNCA Genocea Biosciences > Company Profile
GNCA Genocea Biosciences
0.001
-0.014-93.33%
Symbol
GNCA
Company Name
Genocea Biosciences
Listing Date
02/05/2014
Establishment Date
2006
CEO
Mr. William D. Clark
Market
Pink Market
Employees
74
Securities Type
DR
Fiscal Year Ends
12-31
Address
Cambridge Discovery Park,100 Acorn Park Drive,5th floor
City
Cambridge
Province
Massachusetts
Country
United States of America
Zip code
02140
Phone
1-617-876-8191
Profile
Genocea Biosciences, Inc. engages in the development and commercialization of cancer immunotherapies. The firm uses its proprietary technology platform, ATLAS, to identify clinically relevant antigens of T cells based on actual human immune responses. Its product candidates include GEN-011, an investigational adoptive T cell therapy and GEN-009, a neoantigen cancer vaccine. The company was founded by Robert Paull and Kevin J. Bitterman on August 16, 2006 and is headquartered in Cambridge, MA.
Company Overview
Genocea Biosciences, Inc. engages in the development and commercialization of cancer immunotherapies. The firm uses its proprietary technology platform, ATLAS, to identify clinically relevant antigens of T cells based on actual human immune responses. Its product candidates include GEN-011, an investigational adoptive T cell therapy and GEN-009, a neoantigen cancer vaccine. The company was founded by Robert Paull and Kevin J. Bitterman on August 16, 2006 and is headquartered in Cambridge, MA.
CEO: Mr. William D. Clark
Market: Pink Market
Listing Date: 02/05/2014
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist